Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Literature DB >> 14178017

ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Abstract

Entities: Disease

Keywords: ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FELTY'S SYNDROME; FLUORESCENT ANTIBODY TECHNIC; INFECTION; LE CELLS; OPHTHALMOLOGY; SJOGREN'S SYNDROME

Mesh：

Substances：

Year: 1964 PMID： 14178017 PMCID： PMC1030931 DOI： 10.1136/ard.23.4.306

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

5 in total

1. Incidence of the anti-nuclear factor in human sera.

Authors: W R ALEXANDER; J M BREMNER; J J DUTHIE
Journal: Ann Rheum Dis Date: 1960-12 Impact factor: 19.103

2. THE NATURAL HISTORY OF VASCULAR LESIONS IN RHEUMATOID ARTHRITIS.

Authors: E G BYWATERS; J T SCOTT
Journal: J Chronic Dis Date: 1963-08

3. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.

Authors: A P HALL; W A BARDAWIL; T B BAYLES; A D MEDNIS; N GALINS
Journal: N Engl J Med Date: 1960-10-20 Impact factor: 91.245

4. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors:
Journal: Ann Rheum Dis Date: 1959-03 Impact factor: 19.103

5. A serum factor in lupus erythematosus with affinity for tissue nuclei.

Authors: E J HOLBOROW; D M WEIR; G D JOHNSON
Journal: Br Med J Date: 1957-09-28

5 in total

21 in total

1. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors: D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal: Br J Ophthalmol Date: 1976-03 Impact factor: 4.638

2. Antinuclear factor in rheumatoid arthritis and related diseases.

Authors: D A Pitkeathly; G Taylor
Journal: Ann Rheum Dis Date: 1967-01 Impact factor: 19.103

3. A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

Authors: R N MacSween; T G Dalakos; M K Jasani; J A Boyle; W W Buchanan; R B Goudie
Journal: Clin Exp Immunol Date: 1968-01 Impact factor: 4.330

9. Systemic lupus erythematosus. Classification criteria for systemic lupus erythematosus, with particular reference to lupus-like syndromes.

Authors: E G Bywaters
Journal: Proc R Soc Med Date: 1967-05

10. Precipitating antibodies to nuclear antigens in systemic vasculitis.

Authors: D G Scott; R P Skinner; P A Bacon; P J Maddison
Journal: Clin Exp Immunol Date: 1984-06 Impact factor: 4.330

ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

1. Incidence of the anti-nuclear factor in human sera.

2. THE NATURAL HISTORY OF VASCULAR LESIONS IN RHEUMATOID ARTHRITIS.

3. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.

4. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

5. A serum factor in lupus erythematosus with affinity for tissue nuclei.

1. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

2. Antinuclear factor in rheumatoid arthritis and related diseases.

3. A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

4. Rheumatoid vasculitis.

5. Antinuclear factors.

6. A clinical and serological study of rheumatoid arthritis.

7. DNA haemagglutination test in the diagnosis of systemic lupus erythematosus.

8. Value of test for antinuclear antibodies in rheumatic diseases.

9. Systemic lupus erythematosus. Classification criteria for systemic lupus erythematosus, with particular reference to lupus-like syndromes.

10. Precipitating antibodies to nuclear antigens in systemic vasculitis.